Table 4.
Total | Male | Female | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Mean ± SEM | P value | n | Mean ± SEM | P value | n | Mean ± SEM | P value | |
LA Ang-(1-12) | |||||||||
PO-AF | 8 | 8.27±1.29 | 0.0517 | 7 | 7.31±1.00 | 0.0676 | 1 | 15.00 | N/A |
Non-PO-AF | 3 | 3.36±0.30 | 2 | 3.07±0.08 | 1 | 3.95 | |||
ARB | 3 | 3.93±0.44 | 0.1143 | 2 | 3.92±0.77 | 0.2024 | 1 | 3.95 | N/A |
Non-ARB | 8 | 8.06±1.39 | 7 | 7.07±1.13 | 1 | 15.00 | |||
RA Ang-(1-12) | |||||||||
AF | 4 | 2.48±0.78 | 0.0501 | 3 | 2.67±1.08 | 0.2370 | 1 | 1.91 | N/A |
Non-AF | 13 | 5.14±0.64 | 9 | 4.74±0.87 | 4 | 6.03±0.67 |
PO-AF: postoperative atrial fibrilation; AF: atrial fibrillation; ARB: Angiotensin II receptor blocker.